NIH researchers have developed a magnetic resonance imaging method to monitor how stem cells function once transplanted. The method consists of two FDA-approved drugs that can attach to cells and a third that is detectable by MRI. The technique is being tested in brain tumor patients who receive transplants of engineered neural stem cells.

Related Summaries